4559:TYO
Zeria Pharmaceutical Co Ltd
1 925,00 JPY
arrow_downward
-0,21%(-4,00) 1 d.
9. 10., 15:30:00 GMT+9 · JPY
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre 4559…
Otvoriť
1 923 JPY
Vysoká
1 940 JPY
Nízka
1 919 JPY
Trh. kap.
96,48 mld.
Priem. obj.
170,22 tis.
Objem
77,50 tis.
Dividenda
2,55 %
Štvrťročná dividenda
12 JPY
Prvý obchodný deň po vyplatení dividendy
29. 9. 2026
Pomer cena/zárobky
10,31
Max. za 52 týž.
2 434 JPY
Min. za 52 týž.
1 878 JPY
Výnosy na akciu
187 JPY
Akcie v obehu
50,11 mil.
Počet zamestnancov
2 tis.
Otvoriť
1 923 JPY
Vysoká
1 940 JPY
Nízka
1 919 JPY
Trh. kap.
96,48 mld.
Priem. obj.
170,22 tis.
Objem
77,50 tis.
Dividenda
2,55 %
Štvrťročná dividenda
12 JPY
Prvý obchodný deň po vyplatení dividendy
29. 9. 2026
Pomer cena/zárobky
10,31
Max. za 52 týž.
2 434 JPY
Min. za 52 týž.
1 878 JPY
Výnosy na akciu
187 JPY
Akcie v obehu
50,11 mil.
Počet zamestnancov
2 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Yahoo Finance
·
pred 11 minútami
The Nasdaq-100 Has Gained 20% or More 3 Years Running. This Streak Rests on Far Stronger Earnings Than 1999's.
Kalkine Media
·
pred 20 minútami
Why Does Strategy (NASDAQ:MSTR) Matter After the Rebound?
Seeking Alpha
·
pred 2 hodinami
S&P 500 Forward Earnings Yield (5.3%) Vs. 10-Year Treasury Real Yield (3%): Which One Wins? (NASDAQ:TLT)
Detroit Free Press
·
pred 7 hodinami
How an S&P 500 high, then some reality checks hit markets this week
Profil
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
Informácie o subjekte Zeria Pharmaceutical Co Ltd
Generálny riaditeľSachiaki Ibe
Zamestnanci1,75 tis.
Dátum založenia22. 12. 1955
Hlavné sídlo-
Odvetvie-
Webzeria.co.jp